{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:52:38Z","timestamp":1791996758738,"version":"4.4.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["Y201942205"],"award-info":[{"award-number":["Y201942205"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008867","name":"Department of Education of Zhejiang Province","doi-asserted-by":"publisher","award":["Y201942205"],"award-info":[{"award-number":["Y201942205"]}],"id":[{"id":"10.13039\/501100008867","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81101570"],"award-info":[{"award-number":["81101570"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007194","name":"Wenzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["Y2020146"],"award-info":[{"award-number":["Y2020146"]}],"id":[{"id":"10.13039\/501100007194","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.intimp.2026.116904","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T12:21:43Z","timestamp":1779711703000},"page":"116904","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Fibroblast growth factor 21 ameliorates psoriasiform inflammation and epidermal hyperplasia through the regulation of NF-\u03baB and autophagy pathways"],"prefix":"10.1016","volume":"184","author":[{"given":"Xueran","family":"Guan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianrong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namki","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1929-3328","authenticated-orcid":false,"given":"Jiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4085-5241","authenticated-orcid":false,"given":"Lin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.intimp.2026.116904_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22062979","article-title":"Psoriasis: pathogenesis, comorbidities, and therapy updated","volume":"22","author":"Kanda","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2026.116904_bb0010","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/JLB.5MR0120-439R","article-title":"Keratinocyte: a trigger or an executor of psoriasis?","volume":"108","author":"Ni","year":"2020","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.intimp.2026.116904_bb0015","doi-asserted-by":"crossref","first-page":"16082","DOI":"10.1038\/nrdp.2016.82","article-title":"Psoriasis","volume":"2","author":"Greb","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"2","key":"10.1016\/j.intimp.2026.116904_bb0020","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000495291","article-title":"Psoriasis: keratinocytes or immune cells - which is the trigger?","volume":"235","author":"Benhadou","year":"2019","journal-title":"Dermatology"},{"issue":"2","key":"10.1016\/j.intimp.2026.116904_bb0025","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/sj.jid.5700008","article-title":"Keratinocyte apoptosis in epidermal development and disease","volume":"126","author":"Raj","year":"2006","journal-title":"J. Invest. Dermatol."},{"issue":"2","key":"10.1016\/j.intimp.2026.116904_bb0030","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0092-8674(00)80564-4","article-title":"Cell death in development","volume":"96","author":"Vaux","year":"1999","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.intimp.2026.116904_bb0035","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jdermsci.2004.05.008","article-title":"Evaluation of cell death and proliferation in psoriatic epidermis","volume":"35","author":"Kawashima","year":"2004","journal-title":"J. Dermatol. Sci."},{"issue":"7","key":"10.1016\/j.intimp.2026.116904_bb0040","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/emboj.2008.31","article-title":"Toll-like receptors control autophagy","volume":"27","author":"Delgado","year":"2008","journal-title":"EMBO J."},{"issue":"4","key":"10.1016\/j.intimp.2026.116904_bb0045","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.cell.2011.10.026","article-title":"Autophagy: renovation of cells and tissues","volume":"147","author":"Mizushima","year":"2011","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.intimp.2026.116904_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/cells10051219","article-title":"The PI3K\/Akt pathway: emerging roles in skin homeostasis and a Group of non-Malignant Skin Disorders","volume":"10","author":"Teng","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2026.116904_bb0055","article-title":"Recent updates on the involvement of PI3K\/AKT\/mTOR molecular cascade in the pathogenesis of Hyperproliferative skin disorders","volume":"8","author":"Mercurio","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"issue":"1","key":"10.1016\/j.intimp.2026.116904_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19010171","article-title":"Psoriasis: a STAT3-centric view","volume":"19","author":"Calautti","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2026.116904_bb0065","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1080\/13510002.2019.1658377","article-title":"Salidroside inhibits MAPK, NF-\u03baB, and STAT3 pathways in psoriasis-associated oxidative stress via SIRT1 activation","volume":"24","author":"Xu","year":"2019","journal-title":"Redox Rep."},{"issue":"4","key":"10.1016\/j.intimp.2026.116904_bb0070","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nrm3293","article-title":"Sirtuins as regulators of metabolism and healthspan","volume":"13","author":"Houtkooper","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.intimp.2026.116904_bb0075","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s10753-020-01242-9","article-title":"Role of silent information regulator 1 (SIRT1) in regulating oxidative stress and inflammation","volume":"43","author":"Singh","year":"2020","journal-title":"Inflammation"},{"key":"10.1016\/j.intimp.2026.116904_bb0080","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-physiol-021115-105339","article-title":"Understanding the physiology of FGF21","volume":"78","author":"Fisher","year":"2016","journal-title":"Annu. Rev. Physiol."},{"issue":"3","key":"10.1016\/j.intimp.2026.116904_bb0085","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s00125-014-3458-7","article-title":"The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate intervention and event lowering in diabetes study","volume":"58","author":"Ong","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.intimp.2026.116904_bb0090","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.biopha.2017.02.059","article-title":"FGF21 exerts comparable pharmacological efficacy with adalimumab in ameliorating collagen-induced rheumatoid arthritis by regulating systematic inflammatory response","volume":"89","author":"Yu","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"18","key":"10.1016\/j.intimp.2026.116904_bb0095","doi-asserted-by":"crossref","first-page":"8430","DOI":"10.7150\/thno.44370","article-title":"Modulation of the astrocyte-neuron lactate shuttle system contributes to neuroprotective action of fibroblast growth factor 21","volume":"10","author":"Sun","year":"2020","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.intimp.2026.116904_bb0100","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41419-021-03588-w","article-title":"FGF21 facilitates autophagy in prostate cancer cells by inhibiting the PI3K-Akt-mTOR signaling pathway","volume":"12","author":"Dai","year":"2021","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.intimp.2026.116904_bb0105","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"van der Fits","year":"2009","journal-title":"J. Immunol."},{"issue":"3 Pt B","key":"10.1016\/j.intimp.2026.116904_bb0110","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.jid.2021.06.019","article-title":"Mouse models of psoriasis: a comprehensive review","volume":"142","author":"Gangwar","year":"2022","journal-title":"J. Invest. Dermatol."},{"issue":"23","key":"10.1016\/j.intimp.2026.116904_bb0115","doi-asserted-by":"crossref","first-page":"10466","DOI":"10.7150\/thno.45211","article-title":"Dihydroartemisinin ameliorates psoriatic skin inflammation and its relapse by diminishing CD8(+) T-cell memory in wild-type and humanized mice","volume":"10","author":"Chen","year":"2020","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.intimp.2026.116904_bb0120","first-page":"238","article-title":"Severe psoriasis--oral therapy with a new retinoid","volume":"157","author":"Fredriksson","year":"1978","journal-title":"Dermatologica"},{"issue":"Suppl. 2","key":"10.1016\/j.intimp.2026.116904_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-3083.2009.03389.x","article-title":"European S3-guidelines on the systemic treatment of psoriasis vulgaris","volume":"23","author":"Pathirana","year":"2009","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"2","key":"10.1016\/j.intimp.2026.116904_bb0130","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2133.1992.tb07805.x","article-title":"Is epidermal cell proliferation in psoriatic skin grafts on nude mice driven by T-cell derived cytokines?","volume":"126","author":"Baker","year":"1992","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116904_bb0135","article-title":"The possible role of Dickkopf-1, Golgi protein- 73 and Midkine as predictors of hepatocarcinogenesis: a review and an Egyptian study","volume":"10","author":"AR","year":"2020","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.intimp.2026.116904_bb0140","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1182\/blood-2003-04-1356","article-title":"Distinct pathways of LPS-induced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal\/TIRAP","volume":"103","author":"Andreakos","year":"2004","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.intimp.2026.116904_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23042112","article-title":"Selenium-rich yeast peptide fraction ameliorates Imiquimod-induced psoriasis-like dermatitis in mice by inhibiting inflammation via MAPK and NF-\u03baB signaling pathways","volume":"23","author":"Guo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116904_bb0150","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.lfs.2019.01.019","article-title":"Hesperidin inhibits keratinocyte proliferation and imiquimod-induced psoriasis-like dermatitis via the IRS-1\/ERK1\/2 pathway","volume":"219","author":"Li","year":"2019","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.intimp.2026.116904_bb0155","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1159\/000500470","article-title":"Autophagy in skin diseases","volume":"235","author":"Guo","year":"2019","journal-title":"Dermatology"},{"issue":"5 Pt A","key":"10.1016\/j.intimp.2026.116904_bb0160","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.bbadis.2018.02.003","article-title":"PI3K\/AKT\/mTOR activation and autophagy inhibition plays a key role in increased cholesterol during IL-17A mediated inflammatory response in psoriasis","volume":"1864","author":"Varshney","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"19","key":"10.1016\/j.intimp.2026.116904_bb0165","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of psoriasis: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.intimp.2026.116904_bb0170","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.tem.2019.05.007","article-title":"Going Back to the biology of FGF21: new insights","volume":"30","author":"Lewis","year":"2019","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.intimp.2026.116904_bb0175","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.intimp.2016.05.026","article-title":"Fibroblast growth factor 21 (FGF21) inhibits macrophage-mediated inflammation by activating Nrf2 and suppressing the NF-\u03baB signaling pathway","volume":"38","author":"Yu","year":"2016","journal-title":"Int. Immunopharmacol."},{"issue":"11","key":"10.1016\/j.intimp.2026.116904_bb0180","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41574-020-0386-0","article-title":"The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic","volume":"16","author":"Geng","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.intimp.2026.116904_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.117115","article-title":"The potential of Diosgenin in treating psoriasis: studies from HaCaT keratinocytes and imiquimod-induced murine model","volume":"241","author":"Wu","year":"2020","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.intimp.2026.116904_bb0190","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1007\/s11033-025-10989-z","article-title":"Kaempferol suppresses TLR-2 and TLR-4 coactivation by attenuation of LPS\/LTA-induced inflammation and cellular stress","volume":"52","author":"Haroon","year":"2025","journal-title":"Mol. Biol. Rep."},{"issue":"10","key":"10.1016\/j.intimp.2026.116904_bb0195","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/s41374-021-00621-6","article-title":"Resveratrol promotes skin wound healing by regulating the miR-212\/CASP8 axis","volume":"101","author":"Liu","year":"2021","journal-title":"Lab. Investig."},{"key":"10.1016\/j.intimp.2026.116904_bb0200","article-title":"Anti-inflammatory and antioxidant properties of oleuropein in human keratinocytes characterized by bottom-up proteomics","volume":"15","author":"Li","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"20","key":"10.1016\/j.intimp.2026.116904_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/foods12203748","article-title":"Tart cherry (Prunus cerasus L.) pit extracts protect human skin cells against oxidative stress: unlocking sustainable uses for food industry byproducts","volume":"12","author":"Decot","year":"2023","journal-title":"Foods"},{"issue":"17","key":"10.1016\/j.intimp.2026.116904_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24173064","article-title":"The protective role of Feruloylserotonin in LPS-induced HaCaT cells","volume":"24","author":"He","year":"2019","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.intimp.2026.116904_bb0215","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20102558","article-title":"Apoptotic or Antiproliferative activity of natural products against keratinocytes for the treatment of psoriasis","volume":"20","author":"Huang","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2026.116904_bb0220","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21041275","article-title":"Interleukin-17A and keratinocytes in psoriasis","volume":"21","author":"Furue","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2026.116904_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004725","article-title":"Beta-defensin-2 protein is a serum biomarker for disease activity in psoriasis and reaches biologically relevant concentrations in lesional skin","volume":"4","author":"Jansen","year":"2009","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.intimp.2026.116904_bb0230","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jdermsci.2012.11.002","article-title":"NF-\u03baB: an essential transcription factor in psoriasis","volume":"69","author":"Goldminz","year":"2013","journal-title":"J. Dermatol. Sci."},{"issue":"5","key":"10.1016\/j.intimp.2026.116904_bb0235","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1600-0560.2007.00841.x","article-title":"Evaluation of survivin and NF-kappaB in psoriasis, an immunohistochemical study","volume":"35","author":"Abdou","year":"2008","journal-title":"J. Cutan. Pathol."},{"issue":"3","key":"10.1016\/j.intimp.2026.116904_bb0240","doi-asserted-by":"crossref","first-page":"290","DOI":"10.4103\/0378-6323.196320","article-title":"Autophagy: a brief overview in perspective of dermatology","volume":"83","author":"Nagar","year":"2017","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"issue":"2","key":"10.1016\/j.intimp.2026.116904_bb0245","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.4049\/jimmunol.1001954","article-title":"Autophagy negatively regulates keratinocyte inflammatory responses via scaffolding protein p62\/SQSTM1","volume":"186","author":"Lee","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2026.116904_bb0250","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.3389\/fimmu.2018.01512","article-title":"The therapeutic and pathogenic role of autophagy in autoimmune diseases","volume":"9","author":"Yin","year":"2018","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2026.116904_bb0255","doi-asserted-by":"crossref","DOI":"10.3390\/cells11091479","article-title":"Crosstalk of autophagy and apoptosis","volume":"11","author":"Sorice","year":"2022","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.intimp.2026.116904_bb0260","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s10495-014-0967-2","article-title":"Autophagy and apoptosis: where do they meet?","volume":"19","author":"Mukhopadhyay","year":"2014","journal-title":"Apoptosis"},{"issue":"6","key":"10.1016\/j.intimp.2026.116904_bb0265","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/cbin.11137","article-title":"Cell death: a review of the major forms of apoptosis, necrosis and autophagy","volume":"43","author":"D\u2019Arcy","year":"2019","journal-title":"Cell Biol. Int."},{"issue":"2","key":"10.1016\/j.intimp.2026.116904_bb0270","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1684\/ecn.2009.0155","article-title":"Inflammatory cells and chemokines sustain FGF2-induced angiogenesis","volume":"20","author":"Presta","year":"2009","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.intimp.2026.116904_bb0275","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.yjmcc.2019.09.001","article-title":"Molecular machinery and interplay of apoptosis and autophagy in coronary heart disease","volume":"136","author":"Dong","year":"2019","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"12","key":"10.1016\/j.intimp.2026.116904_bb0280","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1016\/j.jid.2021.06.006","article-title":"Impaired autophagy in psoriasis and atopic dermatitis: a new therapeutic target?","volume":"141","author":"Hailfinger","year":"2021","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116904_bb0285","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13062-025-00703-1","article-title":"Autophagy and mitophagy in dermatological disease: a comprehensive review from molecular pathways to therapeutic frontiers","volume":"21","author":"D\u2019Ambrosio","year":"2025","journal-title":"Biol. Direct"},{"issue":"11","key":"10.1016\/j.intimp.2026.116904_bb0290","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1016\/j.jid.2016.06.618","article-title":"AP1S3 mutations cause skin autoinflammation by disrupting keratinocyte autophagy and up-regulating IL-36 production","volume":"136","author":"Mahil","year":"2016","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.intimp.2026.116904_bb0295","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1486627","article-title":"Mechanisms of autophagy and their implications in dermatological disorders","volume":"15","author":"Xue","year":"2024","journal-title":"Front. Immunol."},{"issue":"5573","key":"10.1016\/j.intimp.2026.116904_bb0300","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1126\/science.296.5573.1655","article-title":"The phosphoinositide 3-kinase pathway","volume":"296","author":"Cantley","year":"2002","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.intimp.2026.116904_bb0305","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nm1162","article-title":"Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model","volume":"11","author":"Sano","year":"2005","journal-title":"Nat. Med."},{"issue":"13","key":"10.1016\/j.intimp.2026.116904_bb0310","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20133153","article-title":"The role of SIRT1 on DNA damage response and epigenetic alterations in cancer","volume":"20","author":"Alves-Fernandes","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116904_bb0315","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/6782872","article-title":"The beneficial roles of SIRT1 in neuroinflammation-related diseases","volume":"2020","author":"Jiao","year":"2020","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"7","key":"10.1016\/j.intimp.2026.116904_bb0320","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1038\/jid.2015.82","article-title":"SIRT1 activation ameliorates Aldara-induced Psoriasiform phenotype and histology in mice","volume":"135","author":"Xie","year":"2015","journal-title":"J. Invest. Dermatol."},{"issue":"9","key":"10.1016\/j.intimp.2026.116904_bb0325","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s40264-018-0673-z","article-title":"Healthcare databases for drug safety research: data validity assessment remains crucial","volume":"41","author":"Rawson","year":"2018","journal-title":"Drug Saf."},{"issue":"1","key":"10.1016\/j.intimp.2026.116904_bb0330","doi-asserted-by":"crossref","first-page":"205","DOI":"10.5114\/aoms.2018.80002","article-title":"Protective effects of benfotiamine on irisin activity in methotrexate-induced liver injury in rats","volume":"16","author":"Erdogan","year":"2020","journal-title":"Arch. Med. Sci."},{"issue":"12","key":"10.1016\/j.intimp.2026.116904_bb0335","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x20165646","article-title":"Non-clinical studies in the process of new drug development - part II: good laboratory practice, metabolism, pharmacokinetics, safety and dose translation to clinical studies","volume":"49","author":"Andrade","year":"2016","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"2","key":"10.1016\/j.intimp.2026.116904_bb0340","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jid.2025.09.005","article-title":"Reevaluating the Imiquimod model: a barrier to translational progress in psoriasis","volume":"146","author":"Smith","year":"2026","journal-title":"J. Invest. Dermatol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926007502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926007502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:33:31Z","timestamp":1791995611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926007502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":68,"alternative-id":["S1567576926007502"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116904","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibroblast growth factor 21 ameliorates psoriasiform inflammation and epidermal hyperplasia through the regulation of NF-\u03baB and autophagy pathways","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116904","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116904"}}